| Application no. and date | 15700725.3 (espacenet) (Federated) (European Patent Register), 20150120 | | Patent/reg. no. and date | DK/EP 3097118, 20180718 | | Publication date | 20161130 | | Priority no. and date | EP 14151769, 20140120 | | EP pub. no. and date |
EP 3097118 20161130 | | Effective date | | | Applicant/owner | Octapharma AG, Seidenstrasse 2
8853 Lachen, CH | | Applicant ref. no. | P021678EPDK1 | | Inventor | WINGE, Stefan, c/o Octapharma AB
Nordenflychtsvägen 55
S-11275 Stockholm, SE,
DADAIAN, Marina, c/o Octapharma AB
Nordenflychtsvägen 55
S-11275 Stockholm, SE,
JOHANSSON, Erica, c/o Octapharma AB
Nordenflychtsvägen 55
S-11275 Stockholm, SE,
FUCHS, Birte, Kamerunerstrasse 49
13351 Berlin, DE | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 38/37 (2006.01) , C07K 14/755 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF FAKTOR VIII MED ET FORBEDRET FVIII:C/FVIII:AG-FORHOLD | | Int. application no. | EP2015051028 | | Int. publication no. | WO2015107222 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
